How Biotech Can Succeed Outside the Hubs
Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.
Sonnet BioTherapeutics Selected for Poster Presentation at the 2025 AACR IO Conference
Session: Poster Session B Abstract title:Combination immunotherapy with an albumin-binding interleukin-12 fusion protein that extends cytokine half-life, targets the tumor microenvironment, and ...
STAT16h
Biogen partners with Stoke Therapeutics to sell severe epilepsy drug
From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...
Johns Hopkins Newsletter1d
Life Design Lab hosts inaugural industry focused career fair
On Jan. 29, the University’s Integrative Learning and Life Design Lab hosted the first inaugural industry-specific career ...
PharmiWeb5d
First-In-Human Data about the Treatment of Muscle-…
ConferenceFirst-In-Human Data about the Treatment of Muscle-Invasive Bladder Cancer with Pentixapharm’s Lu177-PentixaTher to be Presented at ASCO-GU 2025 13.02.2025 / 14:10 CET/CESTThe issuer is ...